Coronavirus Vaccine Update From the FDA – October 5, 2020
Peter Marks, MD, PhD directs the US FDA's Center for Biologics Evaluation and Research (CBER) and will "call the balls and strikes" on any COVID-19 vaccine, according to FDA Commissioner Stephen Hahn, MD. He joins JAMA editor Howard Bauchner, MD for an update on vaccine progress-to-date and prospects for pre-election political interference in the FDA approval process. Recorded October 5, 2020.

• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire.
• Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe

Topics discussed in this interview:
0:00 Introduction
1:02 Background on CBER
2:03 Vaccine application process and EUAs
4:22 Primary data vs. summary tables
5:52 Do you get the playbook from vaccine companies?
7:53 How do you go through the data in these applications?
10:28 Vaccine safety
13:23 Mandating additional safety data
15:18 Data Monitoring Safety Board (DMSB)
16:50 FDA Advisory Committees
20:09 Do these committees weigh in before approval?
21:18 Advisory Committee on Immunization Practices (ACIP)
22:20 When does ACIP weigh in?
23:04 How long do EUAs and BLAs take?
24:17 Preventing DMSBs from prematurely terminating studies
25:35 FDA review meetings
27:42 Requesting additional information before FDA regulatory decisions
28:47 Does the FDA Advisory take a formal vote?
29:16 Career scientists at the FDA
31:34 What has this been like for you personally?
33:11 When will we see the first vaccine application?
34:28 EUA applications before the 2 month followup period

---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwor

Follow the JAMA Network
• https://www.jamanetwork.com
• https://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork

=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.